Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Targeting vaccination against novel infections : risk, age and spatial structure for pandemic influenza in Great Britain

Tools
- Tools
+ Tools

Keeling, Matthew James and White, Peter, 1931-. (2011) Targeting vaccination against novel infections : risk, age and spatial structure for pandemic influenza in Great Britain. Journal of the Royal Society - Interface, Vol.8 (No.58). pp. 661-670. ISSN 1742-5662

[img]
Preview
Text
WRAP_Keeling_J. R. Soc. Interface-2011-Keeling-661-70.pdf - Published Version

Download (735Kb) | Preview
Official URL: http://dx.doi.org/10.1098/rsif.2010.0474

Abstract

The emergence of a novel strain of H1N1 influenza virus in Mexico in 2009, and its subsequent worldwide spread, has focused attention to the question of optimal deployment of mass vaccination campaigns. Here, we use three relatively simple models to address three issues of primary concern in the targeting of any vaccine. The advantages of such simple models are that the underlying assumptions and effects of individual parameters are relatively clear, and the impact of uncertainty in the parametrization can be readily assessed in the early stages of an outbreak. In particular, we examine whether targeting risk-groups, age-groups or spatial regions could be optimal in terms of reducing the predicted number of cases or severe effects; and how these targeted strategies vary as the epidemic progresses. We examine the conditions under which it is optimal to initially target vaccination towards those individuals within the population who are most at risk of severe effects of infection. Using age-structured mixing matrices, we show that targeting vaccination towards the more epidemiologically important age groups (5-14 year olds and then 15-24 year olds) leads to the greatest reduction in the epidemic growth and hence reduces the total number of cases. Finally, we consider how spatially targeting the vaccine towards regions of country worst affected could provide an advantage. We discuss how all three of these priorities change as both the speed at which vaccination can be deployed and the start of the vaccination programme is varied.

Item Type: Journal Article
Subjects: Q Science > QH Natural history > QH426 Genetics
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Science > Life Sciences (2010- )
Faculty of Science > Mathematics
Library of Congress Subject Headings (LCSH): Vaccination, H1N1 influenza -- Vaccination -- Great Britain, Influenza -- Vaccination, Age-structured populations, Spatial ecology
Journal or Publication Title: Journal of the Royal Society - Interface
Publisher: Royal Society Publishing
ISSN: 1742-5662
Date: 6 May 2011
Volume: Vol.8
Number: No.58
Page Range: pp. 661-670
Identification Number: 10.1098/rsif.2010.0474
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access
Funder: Medical Research Council (Great Britain) (MRC), United States. Dept. of Homeland Security. Science and Technology Directorate
References: 1 Anderson, R. & May, R. 1982 Directly transmitted infectious diseases: control by vaccination. Science 215, 1053–1060. (doi:10.1126/science.7063839) 2 McLean, A. 1998 Vaccines and their impact on the control of disease. Br. Med. Bull. 54, 545–556. 3 Fine, P. 1993 Herd immunity: history, theory, practice. Epidemiol. Rev. 15, 265–302. 4 Fenner, F., Henderson, D., Arita, L., Jezek, Z. & Ladnyi, L. 1988 Smallpox and its eradication. Geneva, Switzerland: World Health Organisation. 5 Fine, P. & Clarkson, J. 1983 Measles in England and Wales III: assessing published predictions of the impact of vaccination in incidence. Int. J. Epidemiol. 12, 332–339. (doi:10.1093/ije/12.3.332) 6 McLean, A. & Anderson, R. M. 1988 Measles in developing countries part II. The predicted impact of mass vaccination. Epidem. Infect. 100, 419–442. (doi:10.1017/ S0950268800067170) 7 Jit, M., Choi, Y. H. & Edmunds, W. J. 2008 Economic evaluation of human papillomavirus vaccination in the United Kingdom. Brit. Med. J. 337, a769. (doi:10.1136/ bmj.a769) 8 Baguelin, M., Hoek, A. J. V., Jit, M., Flasche, S., White, P. J. & Edmunds, W. J. 2010 Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 28, 2370–2384. (doi:10. 1016/j.vaccine.2010.01.002) 9 Donaldson, L. 2010 Chief medical officer’s fortnightly bulletin for journalists. (18 March 2010). See http:// webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/ Publichealth/Flu/Swineflu/DH_112078. 10 Department of Health. 2010 Pandemic H1N1 vaccine uptake figures for England by SHA and PCT. See http:// www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_114203. 11 Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C. & Burke, D. S. 2006 Strategies for mitigating an influenza pandemic. Nature 442, 448–452. (doi:10.1038/nature04795) 12 Hall, I. M., Egan, J. R., Barrass, I., Gani, R. & Leach, S. 2007 Comparison of smallpox outbreak control strategies using a spatial metapopulation model. Epidemiol. Infect. 135, 1133–1144. (doi:10.1017/S0950268806007783) 13 Grais, R. F., Conlan, A. J. K., Ferrari, M. J., Djibo, A., Menach, A. L., Bjornstad, O. N. & Grenfell, B. T. 2008 Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J. R. Soc. Interface 5, 67–74. (doi:10.1098/rsif.2007.1038) 14 House, T. & Keeling, M. J. 2009 Household structure and infectious disease transmission. Epidemiol. Infect. 137, 654–661. (doi:10.1017/S0950268808001416) 15 Medlock, J. & Galvani, A. P. 2009 Optimizing influenza vaccine distribution. Science 325, 1705–1708. (doi:10. 1126/science.1175570) 16 Ghani, A. C. et al. 2009 The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Curr. Influenza (RRN1130). (doi:10.1371/currents.RRN1130) 17 Kermack, W. O. & McKendrick, A. G. 1927 A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. A 115, 700–721. (doi:10.1098/rspa.1927.0118) 18 Anderson, R. M. & May, R. 1992 Infectious diseases of humans. Oxford, UK: Oxford University Press. 19 Keeling, M. & Rohani, P. 2008 Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press. 20 Ferguson, N., Keeling, M., Edmunds, W., Gant, R., Grenfell, B., Anderson, R. & Leach, S. 2003 Planning for smallpox outbreaks. Nature 425, 681–685. (doi:10. 1038/nature02007) 21 Keeling, M. J., Woolhouse, M. E. J., May, R. M., Davies, G. & Grenfell, B. T. 2003 Modelling vaccination strategies against foot-and-mouth disease. Nature 421, 136–142. (doi:10.1038/nature01343) 22 Dushoff, J., Plotkin, J. B., Viboud, C., Simonsen, L., Miller, M., Loeb, M. & Earn, D. J. D. 2007 Vaccinating to protect a vulnerable subpopulation. PLoS. Med. 4, 921–927. (doi:10.1371/journal.pmed.0040174) 23 Mylius, S. D., Hagenaars, T. J., Lugner, A. K. &Wallinga, J. 2008 Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 26, 3742–3749. (doi:10.1016/j.vaccine.2008.04.043) 24 Mossong, J. et al. 2008 Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5, 381–391. (doi:10.1371/journal.pmed.0050074) 25 Muller, J. 1998 Optimal vaccination patterns in agestructured populations. Siam J. Appl. Math. 59, 222–241. (doi:10.1137/S0036139995293270) 26 Wallinga, J., van Boven, M. & Lipsitch, M. 2010 Optimizing infectious disease interventions during an emerging epidemic. Proc. Natl Acad. Sci. USA 107, 923–928. (doi:10.1073/pnas.0908491107) 27 Goldstein, E., Apolloni, A., Lewis, B., Miller, J. C., Macauley, M., Eubank, S., Lipsitch, M. & Wallinga, J. 2010 Distribution of vaccine/antivirals and the ‘least spread line’ in a stratified population. J. R. Soc. Interface 7, 755–764. (doi:10.1098/rsif.2009.0393) 28 May, R. & Anderson, R. 1984 Spatial heterogeneity and the design of immunization programs. Math. Biosci. 72, 83–111. (doi:10.1016/0025-5564(84)90063-4) 29 Wu, J. T., Riley, S. & Leung, G. M. 2007 Spatial considerations for the allocation of pre-pandemic influenza vaccination in the United States. Proc. R. Soc B 274, 2811–2817. (doi:10.1098/rspb.2007.0893)
URI: http://wrap.warwick.ac.uk/id/eprint/36456

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us